---

---

entities : Bristol-myers squibb company   

save search

---

Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 0.65% | O: 0.65% H: 0.0% C: 0.0%
conference

---

The Global Antipsychotic Drugs Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
ATAI | $1.85 -5.61% -5.95% 1.5M |

Manufacturing

| 6.52% | O: 1.63% H: 6.95% C: 4.81%
VTRS | $12.17 -0.16% -0.16% 7.1M |

Health Technology

| -0.57% | O: -0.16% H: 0.08% C: -0.41%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.03% | O: -2.99% H: 3.64% C: 3.48%
ABBV | News | $145.2 0.25% 0.0% 6.5M |

Health Technology

| -0.16% | O: -0.46% H: 0.0% C: -0.75%
ACER | $2.235 3.0% 2.91% 210K |

Health Technology

| -4.82% | O: -0.88% H: 2.65% C: -3.98%
global growth market

---

The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
VTRS | $12.17 -0.16% -0.16% 7.1M |

Health Technology

| -0.57% | O: -0.16% H: 0.08% C: -0.41%
NVS | $85.85 -0.29% -0.29% 3.9M |

Health Technology

| -2.46% | O: -1.87% H: 0.01% C: -0.55%
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| 1.78% | O: 0.08% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.03% | O: -2.99% H: 3.64% C: 3.48%
ABBV | News | $145.2 0.25% 0.0% 6.5M |

Health Technology

| -0.16% | O: -0.46% H: 0.0% C: -0.75%
VIR S | $30.14 0.77% 0.76% 860K |

Health Technology

| 2.57% | O: 0.62% H: 2.22% C: 1.94%
TNXP | $1.24 5.09% 4.84% 2.2M |

Health Technology

| 5.08% | O: -1.69% H: 0.0% C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M |

Health Technology

| -5.4% | O: -1.44% H: 0.0% C: 0.0%
GILD | $84.51 3.83% 3.69% 13M |

Health Technology

| 0.6% | O: -1.95% H: 0.16% C: -1.18%
global antiviral growth market

---

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
Published: 2023-02-02 (Crawled : 13:00) - biospace.com/
XYF | News | $3.93 0.57% 0.0% 7.4K |

Finance

| -3.27% | O: 1.49% H: 0.0% C: -4.69%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.03% | O: -2.99% H: 3.64% C: 3.48%
for financial results

---

Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published: 2023-01-27 (Crawled : 13:20) - prnewswire.com
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| -2.09% | O: -0.5% H: 0.0% C: 0.0%
GSK | $34.83 -0.85% 0.03% 3.6M |

Health Technology

| 0.14% | O: 0.06% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 0.19% | O: -0.27% H: 0.0% C: 0.0%
ABBV | News | $145.2 0.25% 0.0% 6.5M |

Health Technology

| -0.77% | O: -0.18% H: 0.0% C: 0.0%
research global antiviral market

---

Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 0.19% | O: -0.27% H: 0.0% C: 0.0%
reblozyl for chmp positive

---

Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 0.19% | O: -0.27% H: 0.0% C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M |

Health Technology

| -2.82% | O: -0.57% H: 0.0% C: 0.0%
treatment for chmp psoriasis positive

---

Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
Published: 2023-01-26 (Crawled : 18:00) - prnewswire.com
NVSEF | $86.075 0 |

Health Technology

| -3.77% | O: -1.1% H: 0.0% C: 0.0%
NVS | $85.85 -0.29% -0.29% 3.9M |

Health Technology

| -6.64% | O: -1.25% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 0.89% | O: 0.7% H: 0.0% C: 0.0%
REGN | $782.76 4.2% 4.03% 1.4M |

Health Technology

| 4.96% | O: 1.46% H: 0.0% C: 0.0%
global report roche market

---

Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Published: 2023-01-26 (Crawled : 13:20) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 0.89% | O: 0.7% H: 0.0% C: 0.0%
breyanzi leukemia trial response transcend

---

Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
TAK | $15.97 1.46% 0.0% 3.5M |

Health Technology

| -2.48% | O: 0.03% H: 0.0% C: 0.0%
NVO | $136.79 3.36% 1.17% 1.8M |

Health Technology

| -2.93% | O: 0.14% H: 0.0% C: 0.0%
NVS | $85.85 -0.29% -0.29% 3.9M |

Health Technology

| -6.62% | O: 0.0% H: 0.0% C: 0.0%
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| -3.43% | O: -1.45% H: 0.0% C: 0.0%
GSK | $34.83 -0.85% 0.03% 3.6M |

Health Technology

| 0.45% | O: 0.23% H: 0.0% C: 0.0%
LLY M | $339.08 2.53% 0.83% 5.7M |

Health Technology

| -6.86% | O: -1.35% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.52% | O: 0.19% H: 0.0% C: 0.0%
ABBV | News | $145.2 0.25% 0.0% 6.5M |

Health Technology

| -3.75% | O: -2.16% H: 0.0% C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M |

Health Technology

| -7.7% | O: -0.92% H: 0.0% C: 0.0%
GILD | $84.51 3.83% 3.69% 13M |

Health Technology

| 0.91% | O: 0.43% H: 0.0% C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M |

Health Technology

| -5.76% | O: -0.9% H: 0.0% C: 0.0%
global report growth market

---

Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published: 2023-01-18 (Crawled : 19:00) - prnewswire.com
NVS | $85.85 -0.29% -0.29% 3.9M |

Health Technology

| -6.62% | O: 0.0% H: 0.0% C: 0.0%
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| -3.43% | O: -1.45% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.52% | O: 0.19% H: 0.0% C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M |

Health Technology

| -7.7% | O: -0.92% H: 0.0% C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M |

Health Technology

| -5.76% | O: -0.9% H: 0.0% C: 0.0%
research report growth market

---

Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
PFE 2 d | $44.06 -0.63% -0.02% 24M |

Health Technology

| -7.2% | O: -2.74% H: 0.0% C: 0.0%
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| -4.36% | O: 0.51% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 2.12% | O: 1.94% H: 0.52% C: -1.09%
ABT | News | $111.79 -0.41% 0.0% 3.8M |

Health Technology

| 0.63% | O: 2.05% H: 0.69% C: -0.1%
SNY | News | $46.02 -2.58% -2.65% 3.5M |

Health Technology

| -6.8% | O: 1.1% H: 0.22% C: 0.02%
GILD | $84.51 3.83% 3.69% 13M |

Health Technology

| -1.11% | O: 0.7% H: 0.37% C: -0.74%
hepatitis global antiviral hiv therapeutics growth market

---

Charles LaPree
Published: 2023-01-12 (Crawled : 21:00) - savarapharma.com
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| -5.52% | O: -0.83% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.81% | O: -0.36% H: 0.37% C: -0.11%

---

Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
Published: 2023-01-11 (Crawled : 14:00) - biospace.com/
JNJ | News | $164.61 -0.56% -0.01% 6.8M |

Health Technology

| -5.51% | O: 0.01% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 2.75% | O: 0.32% H: 0.66% C: 0.6%
WBA A | $37.09 -1.64% -1.67% 5.9M |

Retail Trade

| 3.67% | O: 2.27% H: 0.24% C: -0.22%
GERN | $3.23 -3.29% -3.41% 4.7M |

Health Technology

| 13.99% | O: 11.95% H: 0.0% C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M |

Health Technology

| -8.38% | O: 1.54% H: 0.0% C: 0.0%
for commercial

---

CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
NVS | $85.85 -0.29% -0.29% 3.9M |

Health Technology

| -5.57% | O: 1.97% H: 0.0% C: 0.0%
LLY M | $339.08 2.53% 0.83% 5.7M |

Health Technology

| -7.54% | O: 1.12% H: 0.27% C: -3.89%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.23% | O: 1.06% H: 0.05% C: -2.89%
BNTX | $141.94 -1.7% -1.73% 380K |

Health Technology

| -2.11% | O: 2.93% H: 0.0% C: 0.0%
research car-t therapy market

---

Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors
Published: 2023-01-06 (Crawled : 14:20) - prnewswire.com
NVS | $85.85 -0.29% -0.29% 3.9M |

Health Technology

| -5.5% | O: 0.08% H: 0.0% C: 0.0%
GE | $81.96 -2.36% 0.09% 5.8M |

Electronic Technology

| 19.51% | O: 3.1% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.93% | O: 0.7% H: 0.0% C: 0.0%
BPMC | $45.64 -6.97% -7.49% 810K |

Health Technology

| 1.94% | O: -1.78% H: 0.0% C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M |

Health Technology

| -5.41% | O: 2.43% H: 0.0% C: 0.0%

---

Hestia Insight Inc. Appoints Advisory Board Member to Assist in Company Growth
Published: 2023-01-05 (Crawled : 12:20) - globenewswire.com
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.13% | O: -0.79% H: 0.0% C: 0.0%
growth

---

Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published: 2023-01-04 (Crawled : 21:00) - prnewswire.com
GSK | $34.83 -0.85% 0.03% 3.6M |

Health Technology

| -0.59% | O: -2.81% H: 0.0% C: 0.0%
LLY M | $339.08 2.53% 0.83% 5.7M |

Health Technology

| -8.46% | O: -0.69% H: 0.0% C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.13% | O: -0.79% H: 0.0% C: 0.0%
ABBV | News | $145.2 0.25% 0.0% 6.5M |

Health Technology

| -10.59% | O: -0.39% H: 0.0% C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M |

Health Technology

| -6.74% | O: -3.07% H: 0.0% C: 0.0%
global active report teva market

---

Bristol Myers Squibb to Present at J.P. Morgan’s 41st Annual Healthcare Conference
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.45% | O: -0.58% H: 0.0% C: 0.0%
conference

---

Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M |

Health Technology

| 1.45% | O: -0.58% H: 0.0% C: 0.0%

---

Gainers vs Losers

62%

38%

Top 10 Gainers

---

Your saved searches

---